Antenatal dexamethasone for improving preterm newborn outcomes in low-resource countries: a cost-effectiveness analysis of the WHO ACTION-I trial
journal contribution
posted on 2023-08-25, 04:30authored byKE Eddy, Josh VogelJosh Vogel, N Scott, D Fetene, T Tidhar, OT Oladapo, G Piaggio, MH Nguyen, F Althabe, R Bahl, SPN Rao, A De Costa, S Gupta, AH Baqui, M Shahidullah, SB Chowdhury, S Ahmed, S Sultana, IA Jaben, SS Goudar, SM Dhaded, YV Pujar, SS Vernekar, S Welling, GM Katageri, MR Gudadinni, S Nanda, Z Qureshi, HT Baraka, A Osoti, G Gwako, J Kinuthia, S Ojo, AO Adeponle, AA Idowu, EA Adejuyigbe, O Kuti, BP Kuti, FB Akinkunmi, WE Kubeyinje, HO Raji, O Abiodun, AD Isah, S Ariff, SB Soofi, L Sheikh, A Aamir, F Raza
Antenatal dexamethasone for improving preterm newborn outcomes in low-resource countries: a cost-effectiveness analysis of the WHO ACTION-I trial